This hypothesis is further supported by the ability of the mGlu7 antagonist XAP044 to block LTP within the amygdala, inhibit acquisition of conditioned fear, and reduce anxiety-like behavior (Gee et al., 2014). The gene discussed is GRM7; the disease is Anxiety.